The effect of green coffee extract on dyslipidemia

The effect of green coffee extract supplement on anthropometric indices, lipid profile, oxidized LDL, serum high sensitivity C Reactive Protein and total antioxidant capacity of men with dyslipidemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180128038540N1

Enrollment

Registered

2018-09-17

Start date

2018-01-29

Completion date

Unknown

Last updated

2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia. Disorder of lipoprotein metabolism, unspecified

Interventions

Intervention 1: Intervention group: Consumption of 400 mg capsules of green coffee extract twice a day for half an hour before lunch or dinner, for 8 weeks. Intervention 2: Control group: Taking place

Eligibility

Sex/Gender

Male

Age

25 Years to 55 Years

Inclusion criteria

Inclusion criteria: having dyslipidemia male 25to55 age

Exclusion criteria

Exclusion criteria: Taking lipid lowering drugs weight loss diet vegetarian diet allergy or coffee addiction weight loss or weight gain in the last 6 months

Design outcomes

Primary

Measure	Time frame
Weight. Timepoint: before and after 8 weeks. Method of measurement: digital scale.;Body fat percentage. Timepoint: before and after 8 weeks. Method of measurement: using body composition analyzer omron BF511.;Waist circumference. Timepoint: before and after 8 weeks. Method of measurement: using strip meter.;Total cholesterol. Timepoint: before and after 8 weeks. Method of measurement: total cholesterol test on blood sample.;Triglyceride. Timepoint: before and after 8 weeks. Method of measurement: triglyceride test on blood sample.;Low density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: low density lipoprotein test on blood sample.;High density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: high density lipoprotein test on blood sample.;Oxidised low density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: oxidised low density lipoprotein test on blood sample.;High sensitivity chronic phase reactive protein. Timepoint: before and after 8 weeks. Method of measurement: high sensitivity chronic phase reactive protein test on blood sample.;Total antioxidant capacity. Timepoint: before and after 8 weeks. Method of measurement: total antioxidant capacity test on blood sample.	—

Measure

Time frame

Weight. Timepoint: before and after 8 weeks. Method of measurement: digital scale.;Body fat percentage. Timepoint: before and after 8 weeks. Method of measurement: using body composition analyzer omron BF511.;Waist circumference. Timepoint: before and after 8 weeks. Method of measurement: using strip meter.;Total cholesterol. Timepoint: before and after 8 weeks. Method of measurement: total cholesterol test on blood sample.;Triglyceride. Timepoint: before and after 8 weeks. Method of measurement: triglyceride test on blood sample.;Low density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: low density lipoprotein test on blood sample.;High density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: high density lipoprotein test on blood sample.;Oxidised low density lipoprotein. Timepoint: before and after 8 weeks. Method of measurement: oxidised low density lipoprotein test on blood sample.;High sensitivity chronic phase reactive protein. Timepoint: before and after 8 weeks. Method of measurement: high sensitivity chronic phase reactive protein test on blood sample.;Total antioxidant capacity. Timepoint: before and after 8 weeks. Method of measurement: total antioxidant capacity test on blood sample.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Mohammad shahi

Ahvaz University of Medical Sciences

shahi334@gmail.com+98 61 3373 8253

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026